A critical breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This vital tumor suppressor protein is frequently inactivated in various forms of tumors, resulting https://atozbookmarkc.com/story22164732/nanobodies-revive-p53-the-potential-approach-for-tumor-treatment